发明授权
- 专利标题： Oral controlled release pharmaceutical compositions of bepotastine
- 专利标题（中）： 贝司他宁的口服控释药物组合物
-
申请号： US13982561申请日： 2012-02-03
-
公开(公告)号： US09421165B2公开(公告)日： 2016-08-23
- 发明人: Ashish Ashokrao Deshmukh , Pravin Meghrajji Bhutada , Sajeev Chandran , Shirishkumar Kulkarni
- 申请人： Ashish Ashokrao Deshmukh , Pravin Meghrajji Bhutada , Sajeev Chandran , Shirishkumar Kulkarni
- 申请人地址： IN Mumbai, Maharashtra
- 专利权人： LUPIN LIMITED
- 当前专利权人： LUPIN LIMITED
- 当前专利权人地址： IN Mumbai, Maharashtra
- 代理机构： Merchant & Gould P.C.
- 优先权： IN157/KOL/2011 20110203
- 国际申请： PCT/IB2012/050506 WO 20120203
- 国际公布： WO2012/104818 WO 20120809
- 主分类号： A61K9/00
- IPC分类号： A61K9/00 ; A61K9/20 ; A61K9/24 ; A61K9/28 ; A61K31/4545
摘要：
The present invention relates to oral controlled release pharmaceutical compositions comprising Bepotastine. The oral controlled release pharmaceutical composition comprises Bepotastine or pharmaceutically acceptable salts thereof and at least one release controlling agent. The present invention also provides the use of oral controlled release pharmaceutical compositions of Bepotastine for the treatment of allergic rhinitis and for the treatment of pruritus caused by urticaria.
公开/授权文献
信息查询
